Progress in the Discovery of Small Molecule Modulators of DeSUMOylation
- PMID: 31422931
- DOI: 10.21775/cimb.035.017
Progress in the Discovery of Small Molecule Modulators of DeSUMOylation
Abstract
SUMOylation and DeSUMOylation are reversible protein post-translational modification (PTM) processes involving small ubiquitin-like modifier (SUMO) proteins. These processes have indispensable roles in various cellular processes, such as subcellular localization, gene transcription, and DNA replication and repair. Over the past decade, increasing attention has been given to SUMO-related pathways as potential therapeutic targets. The Sentrin/SUMO-specific protease (SENP), which is responsible for deSUMOylation, has been proposed as a potential therapeutic target in the treatment of cancers and cardiac disorders. Unfortunately, no SENP inhibitor has yet reached clinical trials. In this review, we focus on advances in the development of SENP inhibitors in the past decade.
Similar articles
-
SUMO-specific proteases: SENPs in oxidative stress-related signaling and diseases.Biofactors. 2024 Sep-Oct;50(5):910-921. doi: 10.1002/biof.2055. Epub 2024 Mar 29. Biofactors. 2024. PMID: 38551331 Review.
-
Regulation of post-translational modification in breast cancer treatment.BMB Rep. 2019 Feb;52(2):113-118. doi: 10.5483/BMBRep.2019.52.2.017. BMB Rep. 2019. PMID: 30638182 Free PMC article. Review.
-
The Leishmania donovani SENP Protease Is Required for SUMO Processing but Not for Viability.Genes (Basel). 2020 Oct 14;11(10):1198. doi: 10.3390/genes11101198. Genes (Basel). 2020. PMID: 33066659 Free PMC article.
-
DeSUMOylation: An Important Therapeutic Target and Protein Regulatory Event.DNA Cell Biol. 2015 Nov;34(11):652-60. doi: 10.1089/dna.2015.2933. Epub 2015 Aug 26. DNA Cell Biol. 2015. PMID: 26309017 Review.
-
Noncovalent structure of SENP1 in complex with SUMO2.Acta Crystallogr F Struct Biol Commun. 2019 May 1;75(Pt 5):332-339. doi: 10.1107/S2053230X19004266. Epub 2019 Apr 24. Acta Crystallogr F Struct Biol Commun. 2019. PMID: 31045562 Free PMC article.
Cited by
-
SENP2-mediated SERCA2a deSUMOylation increases calcium overload in cardiomyocytes to aggravate myocardial ischemia/reperfusion injury.Chin Med J (Engl). 2023 Oct 20;136(20):2496-2507. doi: 10.1097/CM9.0000000000002757. Epub 2023 Jul 18. Chin Med J (Engl). 2023. PMID: 37462038 Free PMC article.
-
SUMOtherapeutics for Ischemic Stroke.Pharmaceuticals (Basel). 2023 Apr 29;16(5):673. doi: 10.3390/ph16050673. Pharmaceuticals (Basel). 2023. PMID: 37242456 Free PMC article. Review.
-
Hinokiflavone and Related C-O-C-Type Biflavonoids as Anti-cancer Compounds: Properties and Mechanism of Action.Nat Prod Bioprospect. 2021 Aug;11(4):365-377. doi: 10.1007/s13659-021-00298-w. Epub 2021 Feb 3. Nat Prod Bioprospect. 2021. PMID: 33534099 Free PMC article. Review.
-
Plasma Exosome-Derived SENP1 May Be a Potential Prognostic Predictor for Melanoma.Front Oncol. 2021 Aug 5;11:685009. doi: 10.3389/fonc.2021.685009. eCollection 2021. Front Oncol. 2021. PMID: 34422639 Free PMC article.
-
First comprehensive analysis of lysine succinylation in paper mulberry (Broussonetia papyrifera).BMC Genomics. 2021 Apr 10;22(1):255. doi: 10.1186/s12864-021-07567-5. BMC Genomics. 2021. PMID: 33838656 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous